This article discusses a roadmap project to identify barriers and the progress needed to integrate diversity, equity, and inclusion into trial design and conduct for classical hematologic diseases. Eight barriers were identified and are listed numerically beginning on page 688 under “Summary of findings.”
Due to a production error, the online version incorrectly numbered each barrier with a “1.” The barriers should be numbered 1 through 8.
Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution.
2025
